{"id":"https://openalex.org/W2584422909","doi":"https://doi.org/10.1254/fpj.72.795","title":"Pharmacological studies of penfluridol. (I) The neuropharmacological properties","display_name":"Pharmacological studies of penfluridol. (I) The neuropharmacological properties","publication_year":1976,"publication_date":"1976-01-01","ids":{"openalex":"https://openalex.org/W2584422909","doi":"https://doi.org/10.1254/fpj.72.795","mag":"2584422909"},"language":"en","primary_location":{"id":"doi:10.1254/fpj.72.795","doi":"https://doi.org/10.1254/fpj.72.795","is_oa":true,"landing_page_url":"https://doi.org/10.1254/fpj.72.795","pdf_url":"https://www.jstage.jst.go.jp/article/fpj1944/72/7/72_7_795/_pdf","source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/fpj1944/72/7/72_7_795/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059383397","display_name":"Keizo ITO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keizo ITO","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111769281","display_name":"Seiichi Nurimoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seiichi NURIMOTO","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111848551","display_name":"Keiichi SHINTOMI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keiichi SHINTOMI","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091132274","display_name":"Michio YAMAMURA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michio YAMAMURA","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024119860","display_name":"Ryuichi Ishida","orcid":"https://orcid.org/0000-0003-1012-2784","observed_orcids":["https://orcid.org/0000-0003-1012-2784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryuichi ISHIDA","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108413513","display_name":"Yoshio KOWA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshio KOWA","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac\u5b89\u5168\u6027\u7814\u7a76\u6240","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.13,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.31042383,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"7","first_page":"795","last_page":"813"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5971999764442444,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5971999764442444,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.2750999927520752,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.026799999177455902,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/penfluridol","display_name":"penfluridol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neuropharmacology","display_name":"neuropharmacology","score":0.8289999961853027},{"id":"https://openalex.org/keywords/dopamine-receptor-antagonism","display_name":"dopamine receptor antagonism","score":0.7609999775886536},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8289999961853027},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9520000219345093},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/catalepsy","display_name":"catalepsy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/conditioned-avoidance-response","display_name":"conditioned avoidance response","score":0.6639999747276306},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.7950000166893005},{"id":"https://openalex.org/keywords/anticonvulsant-activity","display_name":"anticonvulsant activity","score":0.6119999885559082},{"id":"https://openalex.org/keywords/duration-of-drug-action","display_name":"duration of drug action","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.9697165489196777},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.9097074270248413},{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.7101632952690125},{"id":"https://openalex.org/C2780476085","wikidata":"https://www.wikidata.org/wiki/Q918193","display_name":"Catalepsy","level":4,"score":0.6449624300003052},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5844191908836365},{"id":"https://openalex.org/C42533223","wikidata":"https://www.wikidata.org/wiki/Q1378064","display_name":"ED50","level":3,"score":0.5534369349479675},{"id":"https://openalex.org/C2777842393","wikidata":"https://www.wikidata.org/wiki/Q407841","display_name":"Reserpine","level":2,"score":0.5281688570976257},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4167678952217102},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33624696731567383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.149465411901474},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.1009553074836731},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.06387630105018616},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1254/fpj.72.795","doi":"https://doi.org/10.1254/fpj.72.795","is_oa":true,"landing_page_url":"https://doi.org/10.1254/fpj.72.795","pdf_url":"https://www.jstage.jst.go.jp/article/fpj1944/72/7/72_7_795/_pdf","source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1254/fpj.72.795","doi":"https://doi.org/10.1254/fpj.72.795","is_oa":true,"landing_page_url":"https://doi.org/10.1254/fpj.72.795","pdf_url":"https://www.jstage.jst.go.jp/article/fpj1944/72/7/72_7_795/_pdf","source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2584422909.pdf","grobid_xml":"https://content.openalex.org/works/W2584422909.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W6817599518","https://openalex.org/W6602972242"],"related_works":["https://openalex.org/W2414603740","https://openalex.org/W2415328966","https://openalex.org/W3100289035","https://openalex.org/W4253835751","https://openalex.org/W2411508965","https://openalex.org/W628951574","https://openalex.org/W2438928222","https://openalex.org/W2029991939","https://openalex.org/W2029169897","https://openalex.org/W2419881853"],"abstract_inverted_index":{"Penfluridol(TLP-607)\u306e\u4e2d\u67a2\u85ac\u7406\u4f5c\u7528\u3092haloperidol\u304a\u3088\u3073chlorpromazine\u306e\u305d\u308c\u3068\u6bd4\u8f03\u691c\u8a0e\u3057\u3066\u4ee5\u4e0b\u306e\u6210\u7e3e\u3092\u5f97\u305f\uff0eTLP-607\u306e\u30a4\u30ccapomorphine\u5614\u5410\u6291\u5236\u4f5c\u7528\u306fhaloperidol\u304a\u3088\u3073chlorpromazine\u306e\u305d\u308c\u3088\u308a\u5f37\u304f\uff0cED50\u5024\u306e2.5\u500d\u91cf\u306e\u6295\u4e0e\u306b\u3088\u308a\u7d041\u9031\u9593\u6301\u7d9a\u3057\u305f\u3002TLP-607\u306e\u6297methamphetamine\u4f5c\u7528\uff0ccatalepsy\u8a98\u767a\u4f5c\u7528\u304a\u3088\u3073\u6761\u4ef6\u56de\u907f\u53cd\u5fdc\u6291\u5236\u4f5c\u7528\u306fhaloperidol\u306e\u4f5c\u7528\u3088\u308a\u5f31\u304f\uff0cchlorpromazine\u306e\u305d\u308c\u3088\u308a\u5f37\u304b\u3063\u305f\u304c\u4f5c\u7528\u6301\u7d9a\u306f\u3044\u305a\u308c\u3082\u4e21\u8005\u3088\u308a\u9577\u304f\uff0c\u305d\u308c\u305e\u308c\u306eED50\u5024\u306e2\u500d\u91cf\u6295\u4e0e\u306b\u3088\u308a\uff0c24\uff5e48\u6642\u9593\u5f8c\u307e\u3067\u4f5c\u7528\u304c\u6301\u7d9a\u3057\u305f\uff0e\u307e\u305f\uff0cTLP-607\u306e\u6b63\u5e38\u4f53\u6e29\u964d\u4e0b\u4f5c\u7528\uff0c\u99b4\u5316\u4f5c\u7528\u304a\u3088\u3073\u93ae\u75db\u4f5c\u7528\u306f\uff0chaloperidol\u304a\u3088\u3073chlorpromazine\u306e\u305d\u308c\u3088\u308a\u5f31\u304b\u3063\u305f\u304c\uff0c\u4f5c\u7528\u6301\u7d9a\u306f\u3044\u305a\u308c\u3082\u4e21\u8005\u3088\u308a\u9577\u304b\u3063\u305f\uff0c\u9ebb\u9154\u5897\u5f37\u4f5c\u7528\uff0c\u5354\u8abf\u904b\u52d5\u6291\u5236\u4f5c\u7528\uff0c\u6297\u75d9\u6523\u4f5c\u7528\u304a\u3088\u3073\u6297reserpine\u4f5c\u7528\u306fTLP-607\u306b\u8a8d\u3081\u3089\u308c\u306a\u304b\u3063\u305f\uff0e\u4ee5\u4e0a\u306e\u7d50\u679c\uff0cTLP-607\u306fhaloperidol\u3084chlorpromazine\u306a\u3069\u306emajor":[0],"tranquilizer\u3068\u540c\u69d8\u306bdopaminc\u53d7\u5bb9\u5668\u906e\u65ad\u4f5c\u7528\u3092\u6709\u3057\u3066\u3044\u308b\u3053\u3068\u304c\u793a\u5506\u3055\u308c\uff0c\u3057\u304b\u3082\u305d\u306e\u4f5c\u7528\u304c\u6975\u3081\u3066\u9577\u6642\u9593\u6301\u7d9a\u3059\u308b\u6297\u7cbe\u795e\u75c5\u85ac\u3067\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u305f\uff0e":[1]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-02-10T00:00:00"}